Catalyst Wire Dossier Catalyst Wire Dossier

LISDEXAMFETAMINE DIMESYLATE

Lisdexamfetamine dimesylate · Sandoz Inc
Drug timelines are a Plus or Pro feature.

43 regulatory and trial events tracked for LISDEXAMFETAMINE DIMESYLATE, covering 2010-02-01 to 2026-03-18. Get the full timeline:

Most recent: FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Camber Pharmaceuticals, Inc.)

See pricing